{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:35:43Z","timestamp":1789263343387,"version":"build-2803163510"},"reference-count":156,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI007485"],"award-info":[{"award-number":["T32AI007485"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 AR069111"],"award-info":[{"award-number":["K08 AR069111"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR077194"],"award-info":[{"award-number":["R01 AR077194"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX004907"],"award-info":[{"award-number":["I01 BX004907"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008893","name":"University of Iowa","doi-asserted-by":"publisher","award":["T32AI007485"],"award-info":[{"award-number":["T32AI007485"]}],"id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.autrev.2022.103061","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T11:57:58Z","timestamp":1644494278000},"page":"103061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["The current state of knowledge of the immune ecosystem in alopecia areata"],"prefix":"10.1016","volume":"21","author":[{"given":"Samuel J.","family":"Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jabbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103061_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0010","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2014.5","article-title":"Gene\u2013environment interaction in autoimmune disease","volume":"16","author":"Ellis","year":"2014","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0015","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by rochester epidemiology project, 1990\u20132009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0020","first-page":"397","article-title":"Epidemiology and burden of alopecia areata: a systematic review","author":"Villasante Fricke","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","article-title":"Alopecia areata: an appraisal of new treatment approaches and overview of current therapies","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0030","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1172\/JCI31942","article-title":"Lymphocytes, neuropeptides, and genes involved in alopecia areata","volume":"117","author":"Gilhar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103061_bb0035","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1529-8019.2011.01413.x","article-title":"Alopecia areata: Clinical presentation, diagnosis, and unusual cases","volume":"24","author":"Finner","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.autrev.2022.103061_bb0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archderm.1963.01590210048007","article-title":"Alopecia Areata","volume":"88","author":"Muller","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-020-1935-3","article-title":"Hyperactivation of sympathetic nerves drives depletion of melanocyte stem cells","volume":"577","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2022.103061_bb0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2002.120604","article-title":"Persistent depigmented regrowth after alopecia areata","volume":"46","author":"Wade","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0055","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1136\/bmj.2.4691.1250","article-title":"Alopecia Areata: A Clinical Study","volume":"2","author":"Anderson","year":"1950","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2022.103061_bb0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.jidsp.5640214","article-title":"The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis","volume":"4","author":"Colombe","year":"1999","journal-title":"J Investigat Dermatol Symp Proc"},{"key":"10.1016\/j.autrev.2022.103061_bb0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/1523-1747.ep12395398","article-title":"Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene","volume":"103","author":"Tarlow","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.gene.2013.05.086","article-title":"The association between interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population","volume":"527","author":"Kalkan","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.autrev.2022.103061_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5021\/ad.2012.24.1.61","article-title":"Association between IL17A\/IL17RA gene polymorphisms and susceptibility to alopecia Areata in the Korean population","volume":"24","author":"Lew","year":"2012","journal-title":"Annal Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0080","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/0300060514549784","article-title":"Investigation of interleukin-12, interleukin-17 and interleukin-23 receptor gene polymorphisms in alopecia areata","volume":"43","author":"Aytekin","year":"2015","journal-title":"J Int Med Res"},{"key":"10.1016\/j.autrev.2022.103061_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2370.2002.00271.x","article-title":"Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction","volume":"29","author":"Tazi-Ahnini","year":"2002","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.autrev.2022.103061_bb0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1034\/j.1399-0039.2002.600604.x","article-title":"Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis","volume":"60","author":"Tazi-Ahnini","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2022.103061_bb0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10238-012-0224-3","article-title":"Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia Areata","volume":"14","author":"Conteduca","year":"2014","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.jid.5700009","article-title":"Major histocompatibility complex class I chain-related gene a polymorphisms and extended haplotypes are associated with familial alopecia Areata","volume":"126","author":"Barahmani","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.gene.6364191","article-title":"Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata","volume":"6","author":"Shimizu","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2022.103061_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2022.103061_bb0115","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/jid.2012.129","article-title":"Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance","volume":"132","author":"Jagielska","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0120","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2022.103061_bb0125","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ejhg.2011.185","article-title":"Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata","volume":"20","author":"Forstbauer","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.autrev.2022.103061_bb0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/1523-1747.ep12382416","article-title":"Alopecia Areata in aging C3H\/HeJ mice","volume":"102","author":"Sundberg","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0135","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1523-1747.1998.00380.x","article-title":"Experimental induction of alopecia Areata-like hair loss in C3H\/HeJ mice using full-thickness skin grafts","volume":"111","author":"McElwee","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0140","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.0022-202X.2005.23692.x","article-title":"Transfer of CD8+ cells induces localized hair loss whereas CD4+\/CD25\u2212 cells promote systemic alopecia areata and CD4+\/CD25+ cells blockade disease onset in the C3H\/HeJ mouse model","volume":"124","author":"McElwee","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0145","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1038\/jid.2015.176","article-title":"Transfer of alopecia areata to C3H\/HeJ mice using cultured lymph node\u2013derived cells","volume":"135","author":"Wang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI551","article-title":"Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice","volume":"101","author":"Gilhar","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103061_bb0155","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/jid.2012.365","article-title":"Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata","volume":"133","author":"Gilhar","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0160","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.1100657","article-title":"A mouse model of clonal CD8+T lymphocyte-mediated alopecia areata progressing to alopecia universalis","volume":"188","author":"Alli","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni1328","article-title":"See no evil, hear no evil, do no evil: the lessons of immune privilege","volume":"7","author":"Niederkorn","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0170","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/eye.2008.382","article-title":"Ocular immune privilege","volume":"23","author":"Taylor","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.autrev.2022.103061_bb0175","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","article-title":"Revisiting the mechanisms of CNS immune privilege","volume":"36","author":"Louveau","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-065X.2006.00438.x","article-title":"The testis in immune privilege","volume":"213","author":"Fijak","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2022.103061_bb0185","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.4049\/jimmunol.178.6.3345","article-title":"Maternal acceptance of the fetus: true human tolerance","volume":"178","author":"Guleria","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-065X.2006.00435.x","article-title":"Cellular and molecular mechanisms of liver tolerance","volume":"213","author":"Crispe","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2022.103061_bb0195","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-065X.2006.00431.x","article-title":"Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora","volume":"213","author":"Iweala","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2022.103061_bb0200","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"1-23","author":"Bertolini","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0205","first-page":"58","article-title":"Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye","volume":"29","author":"Medawar","year":"1948","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.autrev.2022.103061_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/1523-1747.ep12261543","article-title":"A Biologist\u2019s reflections on dermatology","volume":"57","author":"Billingham","year":"1971","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/1523-1747.ep12481002","article-title":"Immune privilege in hair growth","volume":"97","author":"Westgate","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","article-title":"Collapse and restoration of MHC class-I-dependent immune privilege exploiting the human hair follicle as a model","volume":"164","author":"Ito","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2022.103061_bb0225","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.1365-2133.2000.03464.x","article-title":"The human hair follicle immune system: cellular composition and immune privilege","volume":"142","author":"Christoph","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094260","article-title":"Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia Areata","volume":"9","author":"Bertolini","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2022.103061_bb0235","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/jidsymp.1997.17","article-title":"The role of \u03b1-melanocyte-stimulating hormone in cutaneous biology","volume":"2","author":"Luger","year":"1997","journal-title":"J Investigat Dermatol Symp Proc"},{"key":"10.1016\/j.autrev.2022.103061_bb0240","article-title":"Evidence that the bulge region is a site of relative immune privilege in human hair follicles","volume":"1077-1085","author":"Meyer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0245","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0250","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.160.12.5693","article-title":"Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege","volume":"160","author":"Apte","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0255","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/jid.2013.368","article-title":"Hair follicle mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege","volume":"134","author":"Wang","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0260","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/jcp.26134","article-title":"Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice","volume":"233","author":"Li","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2022.103061_bb0265","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","article-title":"Fas ligand-induced apoptosis as a mechanism of immune privilege","volume":"270","author":"Griffith","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.autrev.2022.103061_bb0270","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1523-1747.2003.12182.x","article-title":"Fas-deficient C3.MRL-Tnfrsf6lpr mice and Fas ligand-deficient C3H\/HeJ-Tnfsf6gld mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H\/HeJ mice","volume":"8","author":"Freyschmidt-Paul","year":"2003","journal-title":"J Investigat Dermatol Symp Proc"},{"key":"10.1016\/j.autrev.2022.103061_bb0275","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-\u03b3: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2022.103061_bb0280","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5114\/ada.2019.82826","article-title":"Serum concentrations of selected proinflammatory cytokines in children with alopecia areata","volume":"36","author":"Tabara","year":"2019","journal-title":"Adv Dermatol Allergol\/Post\u0119py Dermatologii i Alergologii"},{"key":"10.1016\/j.autrev.2022.103061_bb0290","article-title":"Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation","volume":"370-380","author":"Glickman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0295","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13718","article-title":"Interferon-gamma serum level and immunohistochemical expression of CD8 cells in tissue biopsies in patients with alopecia areata in correlation with trichoscopic findings","volume":"33","author":"Agamia","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.autrev.2022.103061_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/5693572","article-title":"Increased serum levels of IFN-\u03b3, IL-1\u03b2, and IL-6 in patients with alopecia areata and nonsegmental vitiligo","volume":"2020","author":"Tomaszewska","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.autrev.2022.103061_bb0305","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.0022-202X.2004.23580.x","article-title":"Alopecia areata induced in C3H\/HeJ mice by interferon-gamma: evidence for loss of immune privilege","volume":"124","author":"Gilhar","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0310","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jeas.2006.10.005","article-title":"Failure to induce alopecia areata in C3H\/HeJ mice with exogenous interferon gamma","volume":"43","author":"Sundberg","year":"2007","journal-title":"J Exp Anim Sci"},{"key":"10.1016\/j.autrev.2022.103061_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30997-3","article-title":"Induction of alopecia areata in C3H\/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma","volume":"8","author":"Shin","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2022.103061_bb0320","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2133.2006.07377.x","article-title":"Interferon-\u03b3-deficient mice are resistant to the development of alopecia areata","volume":"155","author":"Freyschmidt-Paul","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0325","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by \u03b3c family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0330","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0335","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/exd.12918","article-title":"Biomarkers of alopecia areata disease activity and response to corticosteroid treatment","volume":"25","author":"Fuentes-Duculan","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0340","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Su\u00e1rez-Fari\u00f1as","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0345","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2230.2009.03523.x","article-title":"Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy","volume":"35","author":"Barahmani","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0350","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000486462","article-title":"Serum levels of interleukin-2 in patients with alopecia Areata: relationship with clinical type and duration of the disease","volume":"4","author":"Kasumagi\u0107-Halilovic","year":"2018","journal-title":"Skin Appendage Disorders"},{"key":"10.1016\/j.autrev.2022.103061_bb0355","article-title":"Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients","volume":"1028-1033","author":"Loh","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2022.103061_bb0360","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.0022-202X.2005.23888.x","article-title":"Reduced expression of Interleukin-2 decreases the frequency of alopecia Areata onset in C3H\/HeJ mice","volume":"125","author":"Freyschmidt-Paul","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0365","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0370","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jid.2020.08.015","article-title":"Low-dose IL-2 for treating moderate to severe alopecia areata: a 52-week multicenter prospective placebo-controlled study assessing its impact on T regulatory cell and NK cell populations","volume":"141","author":"Le Duff","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0375","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.micinf.2011.10.006","article-title":"The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use","volume":"14","author":"Perera","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.autrev.2022.103061_bb0380","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/cimm.1996.0293","article-title":"Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes","volume":"174","author":"Ye","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0385","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","article-title":"IL-15: a central regulator of celiac disease immunopathology","volume":"260","author":"Abadie","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2022.103061_bb0390","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2018.06.029","article-title":"An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation","volume":"142","author":"Song","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0395","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/ijt.ijt_80_18","article-title":"Serum interleukin-15 is a marker of alopecia areata severity","volume":"11","author":"Ebrahim","year":"2019","journal-title":"Int J Trichol"},{"key":"10.1016\/j.autrev.2022.103061_bb0400","article-title":"Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity","volume":"130-137","author":"Bain","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0405","article-title":"Janus kinase inhibitors in autoimmune diseases","volume":"72","author":"O\u2019Shea","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103061_bb0410","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/exd.12265","article-title":"Jakpot! New small molecules in autoimmune and inflammatory diseases","volume":"23","author":"Ghoreschi","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0415","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMoa1110556","article-title":"JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis","volume":"366","author":"Harrison","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0420","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","article-title":"Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis","volume":"367","author":"Fleischmann","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0425","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.autrev.2022.103061_bb0430","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jid.2018.01.032","article-title":"An open-label pilot study to evaluate the efficacy of tofacitinib in moderate to severe patch-type alopecia areata, totalis, and universalis","volume":"138","author":"Jabbari","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0435","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaad.2016.09.007","article-title":"Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients","volume":"76","author":"Liu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0440","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2016.09.006","article-title":"Tofacitinib for the treatment of alopecia areata and variants in adolescents","volume":"76","author":"Craiglow","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0445","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jamadermatol.2017.0001","article-title":"Treatment of alopecia Areata with Tofacitinib","volume":"153","author":"Ibrahim","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0450","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89790","article-title":"Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata","volume":"1","author":"Mackay-Wiggan","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2022.103061_bb0455","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/exd.13060","article-title":"Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers","volume":"25","author":"Jabbari","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0460","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89776","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Kennedy Crispin","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2022.103061_bb0465","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121949","article-title":"High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata","volume":"3","author":"De Jong","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2022.103061_bb0470","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2147\/CCID.S309215","article-title":"A comprehensive literature review of JAK inhibitors in treatment of alopecia areata","volume":"14","author":"Dillon","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0475","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13053","article-title":"The role of Janus kinase inhibitors in the treatment of alopecia areata: a systematic review","volume":"32","author":"Oliveira","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.autrev.2022.103061_bb0480","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.autrev.2022.103061_bb0485","first-page":"e137424","article-title":"A transcriptomic map of murine and human alopecia areata","volume":"5","author":"Borcherding","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2022.103061_bb0490","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41590-020-0758-6","article-title":"The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation","volume":"21","author":"Ng","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0495","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.1501798","article-title":"CXCR3 blockade inhibits T cell migration into the skin and prevents development of alopecia areata","volume":"197","author":"Dai","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0500","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.autrev.2022.103061_bb0505","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/jid.2012.17","article-title":"Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse","volume":"132","author":"McPhee","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0510","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.12.003","article-title":"CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase","volume":"69","author":"Ito","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2022.103061_bb0515","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0190-9622(84)70152-6","article-title":"T cell subpopulaions in alopecia areata","volume":"11","author":"Todes-Taylor","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0520","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2133.1991.tb06054.x","article-title":"The DEBR rat: an animal model of human alopecia areata","volume":"125","author":"Michie","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0525","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2133.1994.tb03371.x","article-title":"Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata","volume":"130","author":"Zhang","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0530","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2133.1999.02705.x","article-title":"Partial restoration of hair growth in the DEBR model for alopecia areata afterin vivodepletion of CD4+ T cells","volume":"140","author":"McElwee","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/925135","article-title":"CD4+T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0540","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","article-title":"Role of Th1 and Th17 cells in organ-specific autoimmunity","volume":"31","author":"Dardalhon","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103061_bb0545","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/34814","article-title":"CCR5 is characteristic of Th1 lymphocytes","volume":"391","author":"Loetscher","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2022.103061_bb0550","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5021\/ad.2017.29.2.156","article-title":"The contributory roles of Th17 lymphocyte and cytotoxic T lymphocyte at the hair bulge region as well as the hair bulb area in the chronic alopecia areata patients","volume":"29","author":"Hong","year":"2017","journal-title":"Annal Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0555","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.3390\/ijms21197015","article-title":"Treg enhancing therapies to treat autoimmune diseases","volume":"21","author":"Eggenhuizen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2022.103061_bb0560","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/cup.13479","article-title":"Regulatory T-cells in alopecia areata","volume":"46","author":"Speiser","year":"2019","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.autrev.2022.103061_bb0565","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000353159","article-title":"Comparison of Interleukin-17-producing cells in different clinical types of alopecia areata","volume":"227","author":"Tojo","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2022.103061_bb0570","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0575","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1523-1747.2002.01745.x","article-title":"Transient CD44 variant isoform expression and reduction in CD4+\/CD25+ regulatory T cells in C3H\/HeJ mice with alopecia areata","volume":"118","author":"Z\u00f6ller","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0580","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/ijd.12808","article-title":"T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-\u03b1) in patients with alopecia areata: association with clinical type and severity","volume":"55","author":"Atwa","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0585","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bjd.12396","article-title":"T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata","volume":"169","author":"Tembhre","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0590","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00403-016-1617-z","article-title":"B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of alopecia areata","volume":"308","author":"Elela","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2022.103061_bb0595","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jaci.2019.08.014","article-title":"IL-12\/IL-23 neutralization is ineffective for alopecia areata in mice and humans","volume":"144","author":"Ortolan","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0600","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000350933","article-title":"Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles","volume":"226","author":"Tanemura","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2022.103061_bb0605","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis \u2014 results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0610","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00403-018-1853-5","article-title":"Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata","volume":"310","author":"Guttman-Yassky","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2022.103061_bb0615","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1684\/ejd.2020.3866","article-title":"Mild therapeutic response of alopecia areata during treatment of psoriasis with secukinumab","volume":"30","author":"Pagnanelli","year":"2020","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0620","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13071","article-title":"New onset alopecia areata during secukinumab therapy","volume":"32","author":"Yalici Armagan","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.autrev.2022.103061_bb0625","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000499030","article-title":"Alopecia diffusa while using Interleukin-17 inhibitors against psoriasis vulgaris","volume":"11","author":"Yajima","year":"2019","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0630","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00403-015-1539-1","article-title":"Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata","volume":"307","author":"Zhang","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2022.103061_bb0635","first-page":"1","article-title":"Phase 2a randomized clinical trial of dupilumab (anti-IL-4R\u03b1) for alopecia areata patients","author":"Guttman-Yassky","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.autrev.2022.103061_bb0640","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0645","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0650","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jaip.2020.01.052","article-title":"Alopecia areata is associated with atopic diathesis: results from a population-based study of 51,561 patients","volume":"8","author":"Kridin","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103061_bb0655","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jdermsci.2020.09.001","article-title":"Pro-inflammatory V\u03b41+T-cells infiltrates are present in and around the hair bulbs of non-lesional and lesional alopecia areata hair follicles","volume":"100","author":"Uchida","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2022.103061_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00761","article-title":"Key features of Gamma-Delta T-cell subsets in human diseases and their immunotherapeutic implications","volume":"8","author":"Lawand","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0665","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/jdv.12932","article-title":"Plasmacytoid dendritic cells in alopecia areata: missing link?","volume":"30","author":"Abou Rahal","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2022.103061_bb0670","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.alit.2019.07.009","article-title":"Plasmacytoid dendritic cells as a possible key player to initiate alopecia areata in the C3H\/HeJ mouse","volume":"69","author":"Ito","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.autrev.2022.103061_bb0675","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1186\/ar567","article-title":"The instructive role of dendritic cells on T-cell responses","volume":"4","author":"Sallusto","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.autrev.2022.103061_bb0680","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2015.11.001","article-title":"Extensive alopecia areata is reversed by IL-12\/IL-23p40 cytokine antagonism","volume":"137","author":"Guttman-Yassky","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0685","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jdcr.2017.07.009","article-title":"Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata","volume":"3","author":"Elkady","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.autrev.2022.103061_bb0690","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/pde.13699","article-title":"Response to ustekinumab in three pediatric patients with alopecia areata","volume":"36","author":"Aleisa","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0695","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.2010.09775.x","article-title":"Type 1 interferon signature in the scalp lesions of alopecia areata","volume":"163","author":"Ghoreishi","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0700","first-page":"103","article-title":"Changes in populations of HLA-DR+CD3+ cells and CD57-CD16+ cells in alopecia areata after corticosteroid therapy","volume":"188","author":"Imai","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2022.103061_bb0705","first-page":"e347","article-title":"An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T cells pathogenic?","volume":"19","author":"Kaufman","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0710","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1084\/jem.20092749","article-title":"Central nervous system (CNS)\u2013resident natural killer cells suppress Th17 responses and CNS autoimmune pathology","volume":"207","author":"Hao","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2022.103061_bb0715","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/art.23760","article-title":"Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production","volume":"58","author":"Lo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103061_bb0720","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10059-011-1057-8","article-title":"IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells","volume":"32","author":"Park","year":"2011","journal-title":"Mol Cells"},{"key":"10.1016\/j.autrev.2022.103061_bb0725","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-2991-2","article-title":"IL-10+ NK and TGF-\u03b2+ NK cells play negative regulatory roles in HIV infection","volume":"18","author":"Jiang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.autrev.2022.103061_bb0730","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jneuroim.2005.02.011","article-title":"Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis","volume":"163","author":"Xu","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0735","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nri1935","article-title":"Reciprocal regulation between natural killer cells and autoreactive T cells","volume":"6","author":"Shi","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2022.103061_bb0740","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaut.2018.04.001","article-title":"iNKT cells ameliorate human autoimmunity: lessons from alopecia areata","volume":"91","author":"Ghraieb","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103061_bb0745","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.1997.03890370063010","article-title":"Hair follicle structures targeted by antibodies in patients with alopecia areata","volume":"133","author":"Tobin","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0750","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/1523-1747.ep12375477","article-title":"Antibodies to hair follicles in alopecia Areata","volume":"102","author":"Tobin","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0755","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2133.1981.tb01200.x","article-title":"Alopecia areata and auto-immunity","volume":"105","author":"Friedmann","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0760","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2133.1992.tb07815.x","article-title":"Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice","volume":"126","author":"Gilhar","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0765","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.0022-202x.2001.01583.x","article-title":"Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdcscid mice","volume":"117","author":"Gilhar","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0770","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaad.2009.01.017","article-title":"Melanocytes: a possible autoimmune target in alopecia areata","volume":"61","author":"Trautman","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103061_bb0775","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1021\/pr100422u","article-title":"Trichohyalin is a potential major autoantigen in human alopecia areata","volume":"9","author":"Leung","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.autrev.2022.103061_bb0780","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jid.2016.04.004","article-title":"Identification of autoantigen epitopes in alopecia areata","volume":"136","author":"Wang","year":"2016","journal-title":"J Invest Dermatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:12:08Z","timestamp":1778821928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":156,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1568997222000313"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103061","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The current state of knowledge of the immune ecosystem in alopecia areata","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103061"}}